Most Recent
Dr Reddy’s settles Millennium’s cancer drug patent suit
Intellectual Property September 18, 2018 1:54 pm By Miklos Bolza

Generic drug maker Dr Reddy’s Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Monster Energy loses challenges to trade mark registrations
Intellectual Property September 6, 2018 6:08 pm By Miklos Bolza

Energy drink giant Monster Energy Company has  come up short in two oppositions to trade mark registrations which it claimed would infringe its marks. Monster […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Millennium wins injunction against Juno over generic cancer drug
Intellectual Property August 27, 2018 11:27 am By Christine Caulfield

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Intellectual Property August 23, 2018 5:41 pm By Miklos Bolza

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Patent suits launched over breakthrough cancer drug
Intellectual Property August 15, 2018 10:25 pm By Miklos Bolza

Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Penfolds maker goes to court over ‘wine in a can’ patents
Intellectual Property August 8, 2018 9:04 pm By Miklos Bolza

Treasury Wine Estates has gone on the offensive in an intellectual property dispute with Melbourne-based “wine in a can” maker Barokes, launching court proceedings alleging […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
17-yr-old trade mark error can’t be fixed, Full Court rules
Intellectual Property July 16, 2018 4:39 pm By Christine Caulfield

Industrial filter manufacturer Vokes has lost its fight to correct a 17-year-old error that removed it as the registered owner of six trade marks, with […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Patron loses opposition to Pirate Bay Rum trade mark
Intellectual Property June 6, 2018 9:51 pm By Miklos Bolza

IP Australia has denied liquor producer Patron Spirits’ opposition to rival Fernbrew’s trade mark for Pirate Bay Rum, saying the mark was not likely to […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Asiago cheese needn’t come from Italy, IP Australia rules
Intellectual Property June 5, 2018 11:13 pm By Miklos Bolza

IP Australia has ruled in part that cheese branded with the Asiago label need not be manufactured in the Asiago region in Italy, striking down an […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
GSK loses patent infringement appeal over slow-release Panadol
Intellectual Property May 11, 2018 9:32 pm By Christine Caulfield

A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.